Table of Contents

1 Global Market Overview

• 1.1 Scope of Statistics
  • 1.1.1 Scope of Products
  • 1.1.2 Scope of Manufacturers
  • 1.1.3 Scope of Application
  • 1.1.4 Scope of Type
  • 1.1.5 Scope of Regions/Countries
• 1.2 Global Market Size

2 Regional Market

• 2.1 Regional Production
• 2.2 Regional Demand
• 2.3 Regional Trade

3 Key Manufacturers

• 3.1 F. Hoffmann-La Roche Ltd.
  • 3.1.1 Company Information
  • 3.1.2 Product & Services
  • 3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.1.4 Recent Development
• 3.2 Genzyme Corporation
  • 3.2.1 Company Information
  • 3.2.2 Product & Services
  • 3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.2.4 Recent Development
• 3.3 Glialogix, Inc.
  • 3.3.1 Company Information
  • 3.3.2 Product & Services
  • 3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.3.4 Recent Development
• 3.4 Kyorin Pharmaceutical Co., Ltd.
  • 3.4.1 Company Information
  • 3.4.2 Product & Services
  • 3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.4.4 Recent Development
• 3.5 MedDay SA
  • 3.5.1 Company Information
  • 3.5.2 Product & Services
  • 3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
  • 3.5.4 Recent Development
• 3.6 Santhera Pharmaceuticals Holding AG
  • 3.6.1 Company Information
  • 3.6.2 Product & Services
  • 3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 3.7 Teva Pharmaceutical Industries Ltd.
  • 3.7.1 Company Information
  • 3.7.2 Product & Services
  • 3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 Major Application

• 4.1 Hospital
  • 4.1.1 Overview
  • 4.1.2 Hospital Market Size and Forecast
• 4.2 Clinic
  • 4.2.1 Overview
  • 4.2.2 Clinic Market Size and Forecast
• 4.3 Others
  • 4.3.1 Overview
  • 4.3.2 Others Market Size and Forecast

5 Market by Type

5.By ApE

• 5.1 ApE
  • 5.1.1 Overview
  • 5.1.2 ApE Market Size and Forecast
• 5.2 Biotin
  • 5.2.1 Overview
  • 5.2.2 Biotin Market Size and Forecast
• 5.3 GZ-402668
  • 5.3.1 Overview
  • 5.3.2 GZ-402668 Market Size and Forecast
• 5.4 Ibudilast
  • 5.4.1 Overview
  • 5.4.2 Ibudilast Market Size and Forecast
• 5.5 Idebenone
  • 5.5.1 Overview
  • 5.5.2 Idebenone Market Size and Forecast
• 5.6 Laquinimod Sodium
  • 5.6.1 Overview
  • 5.6.2 Laquinimod Sodium Market Size and Forecast
• 5.7 Others
  • 5.7.1 Overview
  • 5.7.2 Others Market Size and Forecast

6 Price Overview

• 6.1 Price by Manufacturers
• 6.2 Price by Application
• 6.3 Price by Type

7 Conclusion

Summary
The global Primary Progressive Multiple Sclerosis Treatment market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
F. Hoffmann-La Roche Ltd.
Genzyme Corporation
Glialogix, Inc.
Kyorin Pharmaceutical Co., Ltd.
MedDay SA
Santhera Pharmaceuticals Holding AG
Teva Pharmaceutical Industries Ltd.
Major applications as follows:
Hospital
Clinic
Others
Major Type as follows:
ApE
Biotin
GZ-402668
Ibudilast
Idebenone
Laquinimod Sodium
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa